Announcement Immunis, Inc., a clinical-level biotech establishing creative stem cell empowered biologics for disease and age-based immune dysregulation, has officially published peer-reviewed research in partnership with Dr Micah Drummond from the University of Utah. The discovery published in obe...
Announcement Forlong Biotechnology, a leading clinical-level biotech company, aims to establish a transitional change in cytokine therapies for extreme unmet needs for a certain patient group proudly declared that the first patient has been dosed in a phase 2 clinical trial investigating FL 115 in ...
Announcement The WebMD Ignite, the known strong full-service backup for organisations in the healthcare market, has introduced Ignite Pulsetm. The Ignite Pulsetm is an activation and accurate intelligence solution logically built to navigate healthcare marketers in this constrained budget and AI-c...
Announcement Vizient, the US-based, well-known, large healthcare performance improvement-focused company serving healthcare providers nationwide, applauded the US Food and Drug Administration (FDA) for taking action to advance biosimilar development and publishing new draft guidance. The latest dr...
Announcement PharmaDrug Inc., a leading speciality pharmaceutical company targeting the development, commercialisation and research of natural medicines, have entered a conclusive securities exchange agreement with Canurta Limited Partnership and its limited partners, said to be a parent entity of...
Image Credit: altius Announcement Altius, the AI boosted wellbeing infrastructure company run by Walmart executives Timothy State and David Hoke and former Humana, has signed a long-term contract with Syd Life AI, a UK-based leader in preventive health technologies. This partnership is for...
Image Credit: Tectonic Therapeutic Announcement The Tectonic Therapeutic Inc. has showcased its successful positive topline results from the phase 1b part B acute hemodynamic clinical trial of TX45. It’s a long reactive Fc-relaxin fusion protein in patients going through group 2 PH-H...
Announcement Savara Inc., a US-based clinical-level biopharmaceutical company focusing on rare respiratory diseases, has signed a $75 million royalty funding agreement with RTW Investments, LP, managing the funding process, which is entitled to FDA clearance of MOLBREEZI. The royalty financing wil...
Image Credit: AtriCure Announcement AtriCure, Inc., a well-known innovator in surgical therapies and treatments for atrial fibrillation (Afib), post-operative pain management, and left atrial appendage (LAA) management, proudly announced its first patient enrollment and treatment in the Box lesi...
Image Credit: Harbour Biomed Announcement Harbour BioMed, a leading biopharmaceutical company aiming at the establishment and discovery of novel antibody therapeutics in oncology and immunology, has introduced the first and best-in-class fully fledged human generative AI HCAb (Heavy chain-only a...
